COVID-19 infection may increase the risk of parkinsonism - Remember the Spanish flu?

Eldeeb, Mohamed A; Hussain, Faraz S; Siddiqi, Zaeem A

Eldeeb, Mohamed A; Hussain, Faraz S; Siddiqi, Zaeem A.

Eldeeb MA; Department of Neurology and Neurosurgery, Montreal Neurological Institute McGill University, Montreal, Quebec, Canada. Electronic address: mohamed.eldeeb@mcgill.ca.
Hussain FS; Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Siddiqi ZA; Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Cytokine Growth Factor Rev ; 54: 6-7, 2020 08.

Article in English | MEDLINE | ID: covidwho-548850

Subject(s)

Coronavirus Infections/pathology; Cytokine Release Syndrome/pathology; Influenza, Human/pathology; Parkinson Disease/virology; Pneumonia, Viral/pathology; Betacoronavirus/pathogenicity; COVID-19; Coronavirus Infections/mortality; Cytokines/blood; History, 20th Century; Humans; Influenza Pandemic, 1918-1919; Influenza, Human/mortality; Pandemics; Parkinson Disease/epidemiology; Parkinson Disease/pathology; Pneumonia, Viral/mortality; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / Pneumonia, Viral / Coronavirus Infections / Influenza, Human / Cytokine Release Syndrome Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Cytokine Growth Factor Rev Journal subject: Allergy and Immunology / Biochemistry Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google